August 10, 2017 / 11:40 AM / 11 days ago

BRIEF-Kempharm announces preliminary results from KP415 pharmacokinetic single and multiple dose trial

Aug 10 (Reuters) - Kempharm Inc

* Kempharm announces preliminary results from KP415 pharmacokinetic single and multiple dose trial

* Kempharm - ‍assuming results of KP415.109 trial are positive, we anticipate submitting a new drug application (NDA) with FDA prior to end of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below